跳至主要内容
临床试验/EUCTR2015-004536-35-DE
EUCTR2015-004536-35-DE进行中(未招募)1 期

ipoatrophy in children, adolescents and adults with modern treatment modalities: is there a beneficial effect of insulin glulisine? - The Lipoatrophy-Apidra-Study

Kinder- und Jugendkrankenhaus AUF DER BULT0 个研究点目标入组 24 人开始时间: 2016年3月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with type 1 diabetes and documented lipoatrophy at injection sites on CSII treatment
  • Age between 6 and 40 years (both inclusive)
  • Signed informed consent form from patients or from parents/their guardians if children/youths <18 years
  • Patients must be willing to undergo all study procedures
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 18
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 6
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with previous use of insulin glulisine
  • Patients requiring corticosteroids as treatment medication
  • Patients suffering from severe chronic disease other than T1D or genetic disorder (i.e. Down syndrome etc.)
  • Patients participating in other device or drug studies

研究者

发起方
Kinder- und Jugendkrankenhaus AUF DER BULT

相似试验